Alison Shield

1.1k total citations
33 papers, 755 citations indexed

About

Alison Shield is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Alison Shield has authored 33 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Geriatrics and Gerontology, 8 papers in Economics and Econometrics and 7 papers in Molecular Biology. Recurrent topics in Alison Shield's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Glutathione Transferases and Polymorphisms (5 papers). Alison Shield is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Glutathione Transferases and Polymorphisms (5 papers). Alison Shield collaborates with scholars based in Australia, United States and New Zealand. Alison Shield's co-authors include Barbara J.S. Sanderson, Mark Naunton, Sam Kosari, R. M. Weinshilboum, Bruce W. Eckloff, Bianca A. Thomae, Eric D. Wieben, Philip G. Board, Kasia Bail and Gregory M. Peterson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Molecular Psychiatry.

In The Last Decade

Alison Shield

32 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Shield Australia 16 216 145 124 113 69 33 755
Jeannette Y. Wick United States 11 232 1.1× 71 0.5× 74 0.6× 71 0.6× 66 1.0× 109 876
Fernando Martínez Martínez Spain 17 252 1.2× 235 1.6× 93 0.8× 40 0.4× 129 1.9× 73 1.0k
Elizabeth Stevenson United States 11 192 0.9× 35 0.2× 85 0.7× 52 0.5× 36 0.5× 36 689
Laura Lee Johnson United States 17 167 0.8× 26 0.2× 46 0.4× 87 0.8× 49 0.7× 38 801
Tanja Richter Germany 17 160 0.7× 65 0.4× 223 1.8× 150 1.3× 17 0.2× 30 1.3k
Huiying Liu China 18 104 0.5× 89 0.6× 115 0.9× 27 0.2× 68 1.0× 75 893
Cynthia A. Prows United States 25 380 1.8× 44 0.3× 157 1.3× 345 3.1× 68 1.0× 83 2.0k
Patricia St. Clair United States 12 184 0.9× 38 0.3× 238 1.9× 54 0.5× 61 0.9× 15 927
Elisa J. F. Houwink Netherlands 21 507 2.3× 30 0.2× 141 1.1× 248 2.2× 45 0.7× 44 1.6k
Jutta Huebner Germany 27 221 1.0× 49 0.3× 485 3.9× 287 2.5× 50 0.7× 114 2.0k

Countries citing papers authored by Alison Shield

Since Specialization
Citations

This map shows the geographic impact of Alison Shield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Shield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Shield more than expected).

Fields of papers citing papers by Alison Shield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Shield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Shield. The network helps show where Alison Shield may publish in the future.

Co-authorship network of co-authors of Alison Shield

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Shield. A scholar is included among the top collaborators of Alison Shield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Shield. Alison Shield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shield, Alison, et al.. (2023). Healthy eating blog readership: A cross‐sectional survey in Australian adults. Nutrition & Dietetics. 80(4). 362–371.
2.
Coates, Matthew, Alison Shield, Gregory M. Peterson, & Zahid Hussain. (2022). Prophylactic Cefazolin Dosing in Obesity—a Systematic Review. Obesity Surgery. 32(9). 3138–3149. 11 indexed citations
3.
Kosari, Sam, et al.. (2020). Pharmacist‐led medication reviews in aged care residents with dementia: A systematic review. Australasian Journal on Ageing. 39(4). e478–e489. 8 indexed citations
4.
Kosari, Sam, et al.. (2020). Residential Aged Care Pharmacist: An Australian Pilot Trial Exploring the Impact on Quality Use of Medicines Indicators. SHILAP Revista de lepidopterología. 7(4). 20–20. 15 indexed citations
5.
Kosari, Sam, Kasia Bail, Alison Shield, et al.. (2020). The role of a residential aged care pharmacist: Findings from a pilot study. Australasian Journal on Ageing. 39(3). e466–e471. 11 indexed citations
6.
Deeks, Louise S., et al.. (2020). Understanding medication safety and Charcot-Marie-Tooth disease: a patient perspective. International Journal of Clinical Pharmacy. 42(6). 1507–1514. 1 indexed citations
7.
Kosari, Sam, et al.. (2019). Pharmacist‐led influenza vaccination services in residential aged care homes: A pilot study. Australasian Journal on Ageing. 38(2). 132–135. 14 indexed citations
8.
Kosari, Sam, et al.. (2019). The effect of a residential care pharmacist on medication administration practices in aged care: A controlled trial. Journal of Clinical Pharmacy and Therapeutics. 44(4). 595–602. 40 indexed citations
9.
Shield, Alison, et al.. (2019). Reframing healthy food choices: a content analysis of Australian healthy eating blogs. BMC Public Health. 19(1). 1711–1711. 17 indexed citations
10.
Shield, Alison, et al.. (2019). What is healthy eating? A qualitative exploration. Public Health Nutrition. 22(13). 2408–2418. 42 indexed citations
11.
Naunton, Mark, et al.. (2018). Feasibility of Integrating Residential Care Pharmacists into Aged Care Homes to Improve Quality Use of Medicines: Study Protocol for a Non-Randomised Controlled Pilot Trial. International Journal of Environmental Research and Public Health. 15(3). 499–499. 14 indexed citations
12.
Deeks, Louise S., et al.. (2018). Analytical quality and effectiveness of point-of-care testing in community pharmacies: A systematic literature review. Research in Social and Administrative Pharmacy. 15(5). 483–495. 27 indexed citations
13.
14.
Blackburn, Anneke C., Marjorie Coggan, Alison Shield, et al.. (2011). Glutathione transferase kappa deficiency causes glomerular nephropathy without overt oxidative stress. Laboratory Investigation. 91(11). 1572–1583. 18 indexed citations
15.
Shield, Alison, et al.. (2010). Polymorphisms in the human glutathione transferase Kappa (GSTK1) promoter alter gene expression. Genomics. 95(5). 299–305. 17 indexed citations
16.
Shield, Alison, et al.. (2006). Functional characterisation of ganglioside-induced differentiation-associated protein 1 as a glutathione transferase. Biochemical and Biophysical Research Communications. 347(4). 859–866. 50 indexed citations
17.
Shield, Alison, Bianca A. Thomae, Bruce W. Eckloff, Eric D. Wieben, & R. M. Weinshilboum. (2004). Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Molecular Psychiatry. 9(2). 151–160. 127 indexed citations
18.
Shield, Alison & Barbara J.S. Sanderson. (2003). A recombinant model for assessing the role of GSTM1 in styrene-7,8-oxide toxicity and mutagenicity. Toxicology. 195(1). 61–68. 13 indexed citations
19.
Shield, Alison & Barbara J.S. Sanderson. (2001). Role of glutathione S‐transferase mu (GSTM1) in styrene‐7,8‐oxide toxicity and mutagenicity. Environmental and Molecular Mutagenesis. 37(4). 285–289. 24 indexed citations
20.
Sanderson, Barbara J.S. & Alison Shield. (1996). Mutagenic damage to mammalian cells by therapeutic alkylating agents. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 355(1-2). 41–57. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeannette Y. Wick Breakdown of academic impact, for papers by Fernando Martínez Martínez Breakdown of academic impact, for papers by Elizabeth Stevenson Breakdown of academic impact, for papers by Laura Lee Johnson Breakdown of academic impact, for papers by Tanja Richter Breakdown of academic impact, for papers by Huiying Liu Breakdown of academic impact, for papers by Cynthia A. Prows Breakdown of academic impact, for papers by Patricia St. Clair Breakdown of academic impact, for papers by Elisa J. F. Houwink Breakdown of academic impact, for papers by Jutta Huebner
Rankless by CCL
2026